At a glance
ClinicalIndex Comparison RecordN/ACompleted· 2 enrolled
Drug / intervention
Pro-Omega +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Omega EVAR: Use of Fish Oil to Reduce Inflammation During Endovascular Abdominal Aortic Repair.
In Brief
A clinical study evaluating Pro-Omega and ProOmega Placebo for PAD and Abdominal Aortic Aneurysm. Completed, enrolled 2 participants across 1 site.
Detailed Summary
The purpose of this study is to determine if high-dose PUFA supplementation in patients undergoing EVAR for infra-renal AAA reduces the peri-operative inflammation.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPAD, Abdominal Aortic Aneurysm
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartDec 2016
First PostedJul 2017
Primary CompletionMar 2018
Study CompletionAug 2018
TodayJul 2026
First PostedJul 6, 2017
Enrollment StartDec 1, 2016
Primary CompletionMar 28, 2018
Study CompletionAug 28, 2018
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 9.0 years ago
Interventions
Pro-Omegadietary
Pro-Omega (Nordic Naturals, Watsonville, CA, USA). Each Pro-Omega capsule is 550 mg. Must take 4400 mg/day x 6 months.
ProOmega Placeboother
Placebo Comparator: soybean (Nordic Naturals, Watsonville, CA, USA). Each soybean capsule is 550 mg. Must take 4400 mg/day x 6 months.